Wikidata

(Q34021957)

English

Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival

scientific article

In more languages

Statements

title
Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
author name string
Joaquim Bellmunt
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
Sylvie Négrier
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
Emilio Bajetta
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
Bohuslav Melichar
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
Sergio Bracarda
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
Alain Ravaud
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
Sophie Golding
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
Sangeeta Jethwa
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
Vesna Sneller
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017
page(s)
2144-2150
1 reference
stated in
Europe PubMed Central
PubMed ID
20368553
retrieved
30 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34021957&oldid=1618954324"